Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Downregulated expression of hepatoma-derived growth factor (HDGF) reduces gallbladder cancer cell proliferation and invasion.

Li M, Shen J, Wu X, Zhang B, Zhang R, Weng H, Ding Q, Tan Z, Gao G, Mu J, Yang J, Shu Y, Bao R, Ding Q, Wu W, Cao Y, Liu Y.

Med Oncol. 2013;30(2):587. doi: 10.1007/s12032-013-0587-7. Epub 2013 Apr 23.

PMID:
23609195
[PubMed - indexed for MEDLINE]
2.

Downregulated expression of metastasis associated in colon cancer 1 (MACC1) reduces gallbladder cancer cell proliferation and invasion.

Wang Y, Hong Q, Wang J, Fang Y, Hu C.

Tumour Biol. 2014 Apr;35(4):3771-8. doi: 10.1007/s13277-013-1499-z. Epub 2014 Jan 15.

PMID:
24425103
[PubMed - indexed for MEDLINE]
3.

Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells.

Zhang J, Ren H, Yuan P, Lang W, Zhang L, Mao L.

Cancer Res. 2006 Jan 1;66(1):18-23.

PMID:
16397209
[PubMed - indexed for MEDLINE]
Free Article
4.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

PMID:
20846397
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells.

Guo Z, He Y, Wang S, Zhang A, Zhao P, Gao C, Cao B.

Oncol Rep. 2011 Aug;26(2):511-7. doi: 10.3892/or.2011.1295. Epub 2011 May 4.

PMID:
21567096
[PubMed - indexed for MEDLINE]
6.

Clinical and biological significance of hepatoma-derived growth factor in Ewing's sarcoma.

Yang Y, Li H, Zhang F, Shi H, Zhen T, Dai S, Kang L, Liang Y, Wang J, Han A.

J Pathol. 2013 Nov;231(3):323-34. doi: 10.1002/path.4241. Epub 2013 Aug 22.

PMID:
23878072
[PubMed - indexed for MEDLINE]
7.

Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer.

Tao F, Ye MF, Sun AJ, Lv JQ, Xu GG, Jing YM, Wang W.

World J Gastroenterol. 2014 Jul 28;20(28):9564-9. doi: 10.3748/wjg.v20.i28.9564.

PMID:
25071353
[PubMed - in process]
Free PMC Article
8.

Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.

Lee HJ, Lee K, Lee DG, Bae KH, Kim JS, Liang ZL, Huang SM, Suk Oh Y, Kim HY, Jo DY, Min JK, Kim JM, Lee HJ.

Clin Cancer Res. 2012 Jun 15;18(12):3270-80. doi: 10.1158/1078-0432.CCR-11-2417. Epub 2012 May 2.

PMID:
22553346
[PubMed - indexed for MEDLINE]
Free Article
9.

Prognostic significance of nemo-like kinase (NLK) expression in patients with gallbladder cancer.

Li M, Zhang S, Wang Z, Zhang B, Wu X, Weng H, Ding Q, Tan Z, Zhang N, Mu J, Yang J, Shu Y, Bao R, Ding Q, Wu W, Cao Y, Liu Y.

Tumour Biol. 2013 Dec;34(6):3995-4000. doi: 10.1007/s13277-013-0988-4. Epub 2013 Jul 16.

PMID:
23857283
[PubMed - indexed for MEDLINE]
10.

Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer.

Chen X, Yun J, Fei F, Yi J, Tian R, Li S, Gan X.

Pathol Res Pract. 2012 Aug 15;208(8):437-43. doi: 10.1016/j.prp.2012.03.004. Epub 2012 Jun 8.

PMID:
22682760
[PubMed - indexed for MEDLINE]
11.

Expression of hepatoma-derived growth factor in hepatocellular carcinoma.

Hu TH, Huang CC, Liu LF, Lin PR, Liu SY, Chang HW, Changchien CS, Lee CM, Chuang JH, Tai MH.

Cancer. 2003 Oct 1;98(7):1444-56.

PMID:
14508832
[PubMed - indexed for MEDLINE]
Free Article
12.

Mechanistic study on growth suppression and apoptosis induction by targeting hepatoma-derived growth factor in human hepatocellular carcinoma HepG2 cells.

Tsang TY, Tang WY, Tsang WP, Co NN, Kong SK, Kwok TT.

Cell Physiol Biochem. 2009;24(3-4):253-62. doi: 10.1159/000233250. Epub 2009 Aug 3.

PMID:
19710540
[PubMed - indexed for MEDLINE]
13.

Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor.

Liao F, Dong W, Fan L.

Med Oncol. 2010 Dec;27(4):1219-26. doi: 10.1007/s12032-009-9362-1. Epub 2009 Nov 19.

PMID:
19924574
[PubMed - indexed for MEDLINE]
14.

MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.

Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, Lee YS, Yen TC, Hsieh SY.

J Hepatol. 2012 Sep;57(3):584-91. doi: 10.1016/j.jhep.2012.04.031. Epub 2012 May 18.

PMID:
22613005
[PubMed - indexed for MEDLINE]
15.

The expression and prognostic significance of hepatoma-derived growth factor in oral cancer.

Lin YW, Li CF, Chen HY, Yen CY, Lin LC, Huang CC, Huang HY, Wu PC, Chen CH, Chen SC, Tai MH.

Oral Oncol. 2012 Jul;48(7):629-35. doi: 10.1016/j.oraloncology.2012.01.014. Epub 2012 Feb 21.

PMID:
22361040
[PubMed - indexed for MEDLINE]
16.

Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.

Chen SC, Kung ML, Hu TH, Chen HY, Wu JC, Kuo HM, Tsai HE, Lin YW, Wen ZH, Liu JK, Yeh MH, Tai MH.

J Pathol. 2012 Oct;228(2):158-69. doi: 10.1002/path.3988. Epub 2012 May 23.

PMID:
22247069
[PubMed - indexed for MEDLINE]
17.

Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.

Alvarez H, Corvalan A, Roa JC, Argani P, Murillo F, Edwards J, Beaty R, Feldmann G, Hong SM, Mullendore M, Roa I, IbaƱez L, Pimentel F, Diaz A, Riggins GJ, Maitra A.

Clin Cancer Res. 2008 May 1;14(9):2631-8. doi: 10.1158/1078-0432.CCR-07-1991.

PMID:
18451226
[PubMed - indexed for MEDLINE]
Free Article
18.

Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer.

Ren H, Tang X, Lee JJ, Feng L, Everett AD, Hong WK, Khuri FR, Mao L.

J Clin Oncol. 2004 Aug 15;22(16):3230-7.

PMID:
15310766
[PubMed - indexed for MEDLINE]
Free Article
19.

Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer.

Iwasaki T, Nakagawa K, Nakamura H, Takada Y, Matsui K, Kawahara K.

Oncol Rep. 2005 Jun;13(6):1075-80.

PMID:
15870924
[PubMed - indexed for MEDLINE]
20.

Downregulation of hepatoma-derived growth factor suppresses the malignant phenotype of U87 human glioma cells.

Zhang A, Long W, Guo Z, Guo Z, Cao BB.

Oncol Rep. 2012 Jul;28(1):62-8. doi: 10.3892/or.2012.1768. Epub 2012 Apr 20.

PMID:
22576797
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk